Agios Pharmaceuticals (8AP.F) Q1 2025 Earnings

13FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.62
3.89
9.4
14.9

Details

Expected EPS
-1.6164009185300001
Actual EPS
-1.3765968
Surprise EPS
0.24
Surprise Percent
+14.84%

Description

Agios Pharmaceuticals (8AP.F) has reported earnings of -1.3765968 per share for Q1 2025.

0 Comments

Share your thoughts